Two Day FDA Medical Device Software Regulation Strategy Seminar by Ex-FDA Official (Boston, MA, United States - September 21-22, 2017) - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "FDA's Medical Device Software Regulation Strategy: 2-Day In-Person Seminar by Ex-FDA Official" conference to their offering.

This seminar will focus on addressing these concerns and educating participants on FDA's recent medical device software regulation strategies.

The growth of the medical software industry outpaces the design of FDA's regulatory process. In some instances clinicians have weighed the risk of software failure against the benefits of using a device at all. Device software is often used in conjunction with other software-based devices, but their interoperability was never anticipated.

- How can you anticipate and defend against the malicious remote hacking and shut down of an insulin infusion pump?

- Can one software program defeat the performance capability or back up safety features of another software program?

- When interoperability surface, which software manufacturer takes the lead to solve the problem and deal with proprietary software issues?

This seminar will help those involved in overcoming these commercial and regulatory obstacles. It will highlight the need for firms to remain current with technological tools and strategy to remain competitive, and ideally, outside FDA's regulatory radar.

Going further, it will instruct participants on how to apply these tools and strategies to ensure the following factors:

- Software functionality

- Risk identification

- Software protection

- Problem detection

- Response strategy

For those who have addressed these issues to meet FDA's regulatory expectations, the course instructor, a former FDA official, will help identify a basic centering point to build a regulatory profile for your software products.

Learning Objectives:

- Understanding FDA legal authority

- Applying FDA classifications / risk controls

- Understanding FDA and NIST software guidance

- Identifying the quality system regulation for risk management, software verification and validation

- Identifying cybersecurity issues and developing a planned response

- Identifying and resolving interoperability issues

- Figuring out the scope of FDA's mobile apps regulation

- Learning about bug updates classified as recalls by FDA

- Future device software applications

FDA's risk classification will gradually clarify how it intends to manage the health risks. Risk factors include areas such as the following:

- Cybersecurity

- Interoperability

- Mobile medical apps

- Home use

- Remote use

For more information about this conference visit http://www.researchandmarkets.com/research/kcqwfh/fdas_medical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Medical Devices